Midwest CRC

Crystal Lake, Illinois 60012

0 studies enrolling now · 7 studies all time

What they study most

Cardiovascular Diseases, Chronic Kidney Disease, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Hyperlipidemia, Obesity, Overweight, Overweight or Obesity, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
• Gan & Lee Insulin Glargine Target Type (1) Evaluating Research — Completed
• Gan & Lee Insulin Glargine Target Type (2) Evaluating Research — Completed
• An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus — Completed
• Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro — Withdrawn before enrolling
• A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus — Stopped early
• A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol — Stopped early